Prognostic significance of age in patients with acute ischaemic stroke treated with intravenous thrombolysis.
Marcin WnukLeszek DrabikJustyna DerbiszAgnieszka SłowikPublished in: Neurologia i neurochirurgia polska (2022)
AIS patients treated with reperfusion therapy and aged 80 or more have around a six times higher risk of an unfavourable outcome or death within three months of stroke onset compared to those aged below 60. Higher NIHSS score after IVT, any signs of disability before stroke as measured with mRS, and higher CRP levels are independent risk factors for worse prognosis in the elderly.
Keyphrases
- atrial fibrillation
- cerebral ischemia
- acute ischemic stroke
- pulmonary embolism
- multiple sclerosis
- high dose
- stem cells
- low dose
- coronary artery disease
- community dwelling
- mesenchymal stem cells
- subarachnoid hemorrhage
- blood brain barrier
- percutaneous coronary intervention
- bone marrow
- left ventricular
- replacement therapy